Launched in September 2011, Pink Ribbon Red Ribbon (PRRR) is a public–private partnership that supports African and Latin American countries in accelerating the implementation of their national strategies for the control of women’s cancers. The partnership consists of four organizing members – the George W Bush Institute, the United States President’s Emergency Plan for AIDS Relief (PEPFAR), Susan G Komen for the Cure and the Joint United Nations Program on HIV/AIDS – as well as Becton, Dickinson and Company, the Bill & Melinda Gates Foundation, the Bristol-Myers Squibb Foundation, the Caris Foundation, GlaxoSmithKline (GSK), IBM, Merck, QIAGEN and other organizations with more limited engagement. With initial commitments of $75 million across five years, Pink Ribbon Red Ribbon seeks primarily to reduce mortality from cervical cancer by 25% between 2012 and 2016 among the women screened and treated through the program and to reduce deaths from breast cancer by promoting early detection. Specifically, PRRR focuses on improving access to the human papillomavirus (HPV) vaccine, increasing awareness of breast and cervical cancer prevention, diagnosis and treatment and reducing the stigma that so often surrounds a cancer diagnosis.
|Value||USD 75 Million|